# Aegis Ventures

> Aegis Ventures is a New York healthcare venture studio that co-creates AI-native companies with health systems, entrepreneurs, and scientists. Instead of asking hospitals to buy an outsider's finished product, it uses the 14-member Aegis Digital Consortium to identify operational and clinical problems, shape products, provide early adoption pathways, and help portfolio companies raise capital. Its six-company portfolio spans workflow automation, medical imaging data, patient engagement, emotional voice AI, retinal diagnostics, and fetal brain monitoring.

- **Founded:** 2021
- **Headquarters:** New York, United States
- **Founders:** John Beadle (Co-Founder and Managing Partner), Bill Schoenfeld (Co-Founder and Chairman)
- **Team size:** 33 employees reported in supplied company data; public team page lists a smaller core studio team plus portfolio leadership.
- **Products:** Venture creation platform, Aegis Digital Consortium, Portfolio capital and operating support
- **Notable:** Co-founded six healthcare technology companies across five investment theses., Expanded the Aegis Digital Consortium to 14 U.S. health systems by September 2025., Reports a 100% seed-to-Series A conversion rate across eligible portfolio companies.

## Products & services

- **Venture creation platform** — Hands-on formation and scaling of AI-native healthtech businesses through de novo launches, asset acquisitions, enterprise spinouts, and commercialization partnerships with scientists.
- **Aegis Digital Consortium** — A collaboration of 14 U.S. regional health systems that supplies market signals, workflow expertise, design partnerships, early adoption pathways, and co-investment opportunities.
- **Portfolio capital and operating support** — Capital, recruiting, product strategy, commercialization, customer access, fundraising support, and ecosystem development for co-founded portfolio companies.

## Achievements

- Co-founded six healthcare technology companies across five investment theses.
- Expanded the Aegis Digital Consortium to 14 U.S. health systems by September 2025.
- Reports a 100% seed-to-Series A conversion rate across eligible portfolio companies.
- Reports more than $200 million raised by portfolio companies and 25 strategic partners or co-investors.
- Co-led Avandra's $17.75 million launch financing in February 2025.
- Optain launched with a $12 million seed investment in 2023 and later announced a $26 million Series A.
- Consortium members represent more than $100 billion in operating revenue and about 550,000 employees.

## Latest updates

- **2026-05** — Aegis published a white paper arguing that AI and data-generating medical devices can produce larger, more durable venture outcomes.
- **2026-04** — Aegis and Wavelet Medical announced work on a non-invasive, AI-powered fetal EEG monitoring platform.
- **2026-04** — Digital health executive Bunny Ellerin joined as Chief Ecosystem Officer.
- **2026-01** — Portfolio company Hume AI appointed Andrew Ettinger as CEO.
- **2025-09** — Yale New Haven Health, Keck Medicine of USC, and Hartford HealthCare joined the Digital Consortium, bringing membership to 14 systems.
- **2025-02** — Avandra launched with $17.75 million to expand its federated medical-imaging and clinical-data network.

## Links

- Website: https://aegisventures.com
- LinkedIn: https://www.linkedin.com/company/aegisventures

---

Profile page: https://yespress.io/aegis-ventures
Published by YesPress — https://yespress.io
Last updated: 2026-08-16